Ipsen is hoping to make doctors think twice about prescribing an injected immunotherapy in kidney cancer, as its Cabometyx pill becomes available in most European markets. A tyrosine kinase ...

Cabometyx is now approved for advanced pancreatic and extra-pancreatic NETs, offering a new treatment option for these patients. The phase 3 CABINET trial showed Cabometyx significantly improved ...

(RTTNews) - Exelixis, Inc. (EXEL) Wednesday said that the U.S. Food and Drug Administration (FDA) has approved Cabometyx for the treatment of advanced pancreatic neuroendocrine tumors (pNET ...

Exelixis saw an 11% share price increase over the last quarter, a period marked by significant achievements including the FDA's approval of CABOMETYX® for treating a broader range of pancreatic ...